Disease Treatments
ZaBeCor’s lead drug candidate, Excellair™, is an anti-inflammatory technology based upon siRNA. We believe that Excellair has the potential to treat multiple indications, which include, but are not limited to, the following:
- Asthma
- Allergy
- Lung inflammatory conditions
- COPD
- ARDS
- Influenza / Avian flu
- Rheumatoid arthritis
- Systemic lupus erythematosus
- Cystitis
- Conjunctivitis / Eye Inflammatory Disorders
- Parkinson’s Disease
- Atherosclerosis
- Topical Applications